{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:50:16Z","timestamp":1793771416548,"version":"4.6.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Structure"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.molstruc.2021.131481","type":"journal-article","created":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T16:08:01Z","timestamp":1631462881000},"page":"131481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Evaluating anti-coronavirus activity of some phosphoramides and their influencing inhibitory factors using molecular docking, DFT, QSAR, and NCI-RDG studies"],"prefix":"10.1016","volume":"1248","author":[{"given":"Khodayar","family":"Gholivand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Mohammadpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Pooyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roohollah","family":"Roohzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molstruc.2021.131481_bib0001","series-title":"Coronavirus disease (COVID-19) Situation Report \u2013 121","author":"Organization","year":"2020"},{"key":"10.1016\/j.molstruc.2021.131481_bib0002","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel Coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.molstruc.2021.131481_bib0003","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molstruc.2021.131481_bib0004","first-page":"R155789","article-title":"Dataset on the COVID-19 Pandemic Situation in Tunisia with Application to SIR Model","volume":"PPR:","author":"Lassoued","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.molstruc.2021.131481_bib0005","doi-asserted-by":"crossref","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and Homoharringtonine Inhibit SARS-CoV-2 Replication in vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.molstruc.2021.131481_bib0006","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molstruc.2021.131481_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117652","article-title":"In silico studies on therapeutic agents for COVID-19: drug repurposing approach","volume":"252","author":"Shah","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.molstruc.2021.131481_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104541","article-title":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase","volume":"169","author":"Brown","year":"2019","journal-title":"Antivir. Res."},{"issue":"396","key":"10.1016\/j.molstruc.2021.131481_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molstruc.2021.131481_bib0010","unstructured":"Adaptive COVID-19 Treatment Trial. ClinicalTrials.gov identifier: NCT04280705. Posted February 21, 2020. Accessed March 19, 2020. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04280705?term=remdesivir&cond=covid-19&draw=2&rank=5."},{"key":"10.1016\/j.molstruc.2021.131481_bib0011","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.molstruc.2021.131481_bib0012","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.chembiol.2004.08.011","article-title":"High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase","volume":"11","author":"Blanchard","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.molstruc.2021.131481_bib0013","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.molstruc.2021.131481_bib0014","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1021\/jm060207o","article-title":"Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease","volume":"49","author":"Lu","year":"2006","journal-title":"J. Med. Chem."},{"issue":"2000028","key":"10.1016\/j.molstruc.2021.131481_bib0015","first-page":"1","article-title":"Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds","volume":"39","author":"Ton","year":"2020","journal-title":"Mol. Inform."},{"key":"10.1016\/j.molstruc.2021.131481_bib0016","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses-drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molstruc.2021.131481_bib0017","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.chembiol.2003.09.002","article-title":"The process of structure-based drug design","volume":"10","author":"Anderson","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.molstruc.2021.131481_bib0018","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.molstruc.2021.131481_bib0019","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/1389450117666160101120822","article-title":"Computer aided drug design for multi-target drug design: SAR\/QSAR, molecular docking and pharmacophore methods","volume":"18","author":"Abdolmaleki","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.molstruc.2021.131481_bib0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1039\/a901981b","article-title":"Natural guanidine derivatives","volume":"19","author":"Berlinck","year":"2002","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.molstruc.2021.131481_bib0021","first-page":"36","article-title":"Imidazole and its biological activities: a review","volume":"1","author":"Shalini","year":"2010","journal-title":"Der Chem. Sin."},{"key":"10.1016\/j.molstruc.2021.131481_bib0022","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1021\/jm701207m","article-title":"Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities","volume":"50","author":"Ohara","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.131481_bib0023","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11094-019-01976-3","article-title":"Recent advances in antiviral benzimidazole derivatives: a mini review","volume":"53","author":"Kanwal","year":"2019","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.molstruc.2021.131481_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111866","article-title":"Preliminary SAR and biological evaluation of potent HIV-1 protease inhibitors with pyrimidine bases as novel P2 ligands to enhance activity against DRV-resistant HIV-1 variants","volume":"185","author":"Zhu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.131481_bib0025","doi-asserted-by":"crossref","first-page":"8860","DOI":"10.1021\/jm401278d","article-title":"Structure-activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3, 5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activity","volume":"56","author":"Younis","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.131481_bib0026","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1021\/acsomega.8b00128","article-title":"Highly potent, stable, and selective dimeric hetarylpropylguanidine-type histamine H2 receptor agonists","volume":"3","author":"Pockes","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.molstruc.2021.131481_bib0027","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1021\/jm200696v","article-title":"Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion","volume":"54","author":"Yu","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.131481_bib0028","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejmech.2006.10.003","article-title":"Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1, 3, 4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1, 3, 4-thiadiazoles","volume":"42","author":"Kadi","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.131481_bib0029","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1021\/jf0201677","article-title":"Synthesis, fungicidal activity, and 3D-QSAR of pyridazinone-substituted 1, 3, 4-oxadiazoles and 1, 3, 4-thiadiazoles","volume":"50","author":"Zou","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.molstruc.2021.131481_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1248\/cpb.c12-00582","article-title":"Synthesis of novel phosphorylated guanidine derivatives from cyanamide and their anti-inflammatory activity","volume":"61","author":"Katla","year":"2013","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.molstruc.2021.131481_bib0031","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pestbp.2019.03.010","article-title":"Synthesis, crystal structure, insecticidal activities, molecular docking and QSAR studies of some new phospho guanidines and phospho pyrazines as cholinesterase inhibitors","volume":"157","author":"Gholivand","year":"2019","journal-title":"Pestic. Biochem. Physiol."},{"key":"10.1016\/j.molstruc.2021.131481_bib0032","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0022-328X(96)06689-2","article-title":"Synthesis of phosphinyl, thiophosphinyl and phosphonio guanidines","volume":"529","author":"Inguimbert","year":"1997","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.molstruc.2021.131481_bib0033","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12039-019-1721-7","article-title":"Diphenyl phosphate creatine immobilized on magnetite nanoparticles: an efficient and recyclable catalyst for Aza-Michael reaction","volume":"132","author":"Pazoki","year":"2020","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.molstruc.2021.131481_bib0034","doi-asserted-by":"crossref","first-page":"8828","DOI":"10.1002\/slct.201701157","article-title":"Synthesis, crystal structure, fluorescence assay, molecular docking and QSAR\/QSPR studies of Temephos derivatives as human and insect cholinesterase inhibitors","volume":"2","author":"Gholivand","year":"2017","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.molstruc.2021.131481_bib0035","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bioorg.2019.01.064","article-title":"Synthesis, crystal structure and biological evaluation of new phosphoramide derivatives as urease inhibitors using docking, QSAR and kinetic studies","volume":"86","author":"Gholivand","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.molstruc.2021.131481_bib0036","first-page":"44","article-title":"In silico study of various antiviral drugs, vitamins, and natural substances as potential binding compounds with SARS-CoV-2 main protease","volume":"1","author":"Alabboud","year":"2020","journal-title":"DYSONA Life Sci."},{"key":"10.1016\/j.molstruc.2021.131481_bib0037","first-page":"2020030333","article-title":"Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: an in silico strategy unveils a hope against CORONA","author":"Adem","year":"2020","journal-title":"Preprints"},{"key":"10.1016\/j.molstruc.2021.131481_bib0038","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.molstruc.2021.131481_bib0039","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1021\/ci9000234","article-title":"Hydrogen bonding, electrostatic potential, and molecular design","volume":"49","author":"Kenny","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.molstruc.2021.131481_bib0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.saa.2010.09.016","article-title":"Spectroscopic investigations and quantum chemical computational study of (E)-4-methoxy-2-[(p-tolylimino) methyl] phenol","volume":"78","author":"Kosar","year":"2011","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.molstruc.2021.131481_bib0041","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00498259409043243","article-title":"Interaction of a series of nitriles with the alcohol-inducible isoform of P450: computer analysis of structure-activity relationships","volume":"24","author":"Lewis","year":"1994","journal-title":"Xenobiotica"},{"key":"10.1016\/j.molstruc.2021.131481_bib0042","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn: a multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.molstruc.2021.131481_bib0043","series-title":"Frontier Orbitals and Organic Chemical Reactions","author":"Fleming","year":"1977"},{"key":"10.1016\/j.molstruc.2021.131481_bib0044","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6307457","article-title":"Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: a molecular docking study","volume":"2020","author":"Tallei","year":"2020","journal-title":"Scientifica"},{"key":"10.1016\/j.molstruc.2021.131481_bib0045","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.bmc.2004.08.013","article-title":"Electrophilicity index as a possible descriptor of biological activity","volume":"12","author":"Parthasarathi","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.131481_bib0046","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/ja983494x","article-title":"Electrophilicity index","volume":"121","author":"Parr","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.molstruc.2021.131481_bib0047","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1021\/ja00364a005","article-title":"Absolute hardness: companion parameter to absolute electronegativity","volume":"105","author":"Parr","year":"1983","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.molstruc.2021.131481_bib0048","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1021\/ja100936w","article-title":"Revealing noncovalent interactions","volume":"132","author":"Johnson","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.molstruc.2021.131481_bib0049","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.molstruc.2021.131481_bib0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.comptc.2012.07.014","article-title":"Non-covalent interaction via the reduced density gradient: independent atom model vs experimental multipolar electron densities","volume":"998","author":"Saleh","year":"2012","journal-title":"Comput. Theor. Chem."},{"key":"10.1016\/j.molstruc.2021.131481_bib0051","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1021\/cr00088a005","article-title":"Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint","volume":"88","author":"Reed","year":"1988","journal-title":"Chem. Rev."},{"key":"10.1016\/j.molstruc.2021.131481_bib0052","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.molstruc.2021.131481_bib0053","series-title":"BIOVIA, Discovery Studio Modeling Environment","year":"2015"},{"key":"10.1016\/j.molstruc.2021.131481_bib0054","article-title":"DRAGON-Software for the calculation of molecular descriptors. Version 4.0 for","author":"Todeschini","year":"2004","journal-title":"Windows"},{"key":"10.1016\/j.molstruc.2021.131481_bib0055","series-title":"Gaussian 03, Revision B.04","author":"Frisch","year":"2003"},{"key":"10.1016\/j.molstruc.2021.131481_bib0056","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.etap.2015.08.032","article-title":"Quantitative structure\u2013activity\/ecotoxicity relationships (QSAR\/QEcoSAR) of a series of phosphonates","volume":"40","author":"Petrescu","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.molstruc.2021.131481_bib0057","first-page":"1329","article-title":"A hybrid genetic algorithm-neural network strategy for simulation optimization","volume":"170","author":"Wang","year":"2005","journal-title":"Appl. Math. Comput."}],"container-title":["Journal of Molecular Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022286021016094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022286021016094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T23:51:47Z","timestamp":1758325907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022286021016094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":57,"alternative-id":["S0022286021016094"],"URL":"https:\/\/doi.org\/10.1016\/j.molstruc.2021.131481","relation":{},"ISSN":["0022-2860"],"issn-type":[{"value":"0022-2860","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating anti-coronavirus activity of some phosphoramides and their influencing inhibitory factors using molecular docking, DFT, QSAR, and NCI-RDG studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molstruc.2021.131481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131481"}}